Deleted Tweets From Scott Gottlieb, R-D.C.

RT @HankGreelyLSJU: I remember Reggie Jackson, when w/the Angels, telling reporters that reports of his imminent retirement were wrong. "But you fellas keep saying it. Sooner or later, you're going to be right." Comes w/the territory, @SGottliebFDA https://t.co/zFyfulFlbf

RT @SGottliebFDA: We know the shutdown imposes hardships on our workforce. We're taking steps to try and mitigate personal impacts wh… https://t.co/Dl5mLrsrFZ

3/4 Please pay careful attention to FDA’s lists of recalled products for the most accurate and up-to-date information. https://t.co/HZb3YT0060

2/4 Many of the products under current recalls are combination products that include an ARB (e.g. valsartan+amlodipine+HCTZ), but single active ingredient products without an ARB, such as amlodipine by itself are NOT under these recalls.

Want to learn more about ways that patients, caregivers, and advocates can get involved at FDA? Contact Patient Affairs - we work closely with all #FDA Centers to make sure your voice is heard at FDA. https://t.co/lKQr0uXD4U https://t.co/Z5ugnH1baL

2/2 Not all Torrent losartan-containing products distributed in the U.S. are being recalled. We’ll continue to investigate these impurities and provide updates to consumers, HCPs and industry when possible. We’ve updated the list of recalled products https://t.co/qNsSYgdXLS

THREAD: #FDA is committed to sharing the latest info re: angiotensin II receptor blocker (ARB) recalls including valsartan, losartan and irbesartan and want to clarify which products are and are not under recall. https://t.co/HZb3YT0060 1/4

Flu activity is picking up nationwide. It looks like a predominant H1N1 season which tends to peak later. There’s still time to get your flu vaccine. #VaccinesWork https://t.co/tBwUqj0aTr

4/4 We also urge patients to speak with their pharmacists and healthcare providers to confirm that their product is actually affected by the recall. #FDA has resources via @FDA_Drug_Info for consumers and HCPs. Follow us and visit our ARB recall website https://t.co/HZb3YT0060.

RT @pewtrusts: What is @US_FDA doing to get urgently needed treatments to patients with serious and life-threatening infections? Answers and more from @SGottliebFDA: https://t.co/g0qG7FdHkz

#FDA treats products containing cannabis or cannabis-derived compounds as we do any other FDA-regulated products. These products are subject to the same authorities and requirements as FDA-regulated products containing any other substance. https://t.co/LOpLWuqInx

RT @theNCI: The most commonly used types of e-cigarettes among teens may deliver very high levels of nicotine: https://t.co/yWNxWNHML1 #CancerCurrents https://t.co/mjYbyiQ7Df

RT @FDArecalls: Shamrock Farms Issues Voluntary Recall of 2% Reduced Fat Vanilla Half Gallon Milk Due to Undeclared Almonds https://t.co/VEWjTt0rXf

RT @SecAzar: Happy birthday to the US Public Health Service Commissioned Corps. I’m proud of my colleagues who continue the Comm… https://t.co/OCbWOfrBjp

RT @FDArecalls: Olde York Potato Chips Issues Allergy Alert on Undeclared Milk in One Lot of Clancy's Wavy Potato Chips 10 Oz https://t.co/TTSdoe1qEP

@sarahdespres @US_FDA This is critical public health activity, and excepted work, and it will go on. Our very dedicated professionals who will continue this mission will, however, be working subject to other limitations, that affect salary and reimbursement, as a result of the lapse in appropriations.

THREAD: We have received questions about how much user fee funding we have as carryover balances from 2018; to allow us to continue to work on user-fee related applications and medical product development programs. Some facts and details here:

First a few facts: We cannot accept new 2019 user fees which means we cannot accept new medical product applications, unless it is user-fee-program related but doesn’t require the payment of a user fee; which is a very small subset of applications.

#FDA is a critical institution that provides services and protections Americans depend on to sustain, improve their lives. We continue our mission through challenging circumstances. I’m grateful to our professional staff, who are carrying on that mission amidst personal challenge

But we continue work on existing applications where user fees were paid prior to Dec. 22, 2018. Among our medical product user fee programs, the one that will run out of carryover balance first is likely PDUFA which funds new drug review. We have about one month of funding left.

RT @HankGreelyLSJU: I remember Reggie Jackson, when w/the Angels, telling reporters that reports of his imminent retirement were wrong. "But you fellas keep saying it. Sooner or later, you're going to be right." Comes w/the territory, @SGottliebFDA https://t.co/zFyfulFlbf

RT @SGottliebFDA: We know the shutdown imposes hardships on our workforce. We're taking steps to try and mitigate personal impacts wh… https://t.co/Dl5mLrsrFZ

3/4 Please pay careful attention to FDA’s lists of recalled products for the most accurate and up-to-date information. https://t.co/HZb3YT0060

2/4 Many of the products under current recalls are combination products that include an ARB (e.g. valsartan+amlodipine+HCTZ), but single active ingredient products without an ARB, such as amlodipine by itself are NOT under these recalls.

Want to learn more about ways that patients, caregivers, and advocates can get involved at FDA? Contact Patient Affairs - we work closely with all #FDA Centers to make sure your voice is heard at FDA. https://t.co/lKQr0uXD4U https://t.co/Z5ugnH1baL

2/2 Not all Torrent losartan-containing products distributed in the U.S. are being recalled. We’ll continue to investigate these impurities and provide updates to consumers, HCPs and industry when possible. We’ve updated the list of recalled products https://t.co/qNsSYgdXLS

THREAD: #FDA is committed to sharing the latest info re: angiotensin II receptor blocker (ARB) recalls including valsartan, losartan and irbesartan and want to clarify which products are and are not under recall. https://t.co/HZb3YT0060 1/4

Flu activity is picking up nationwide. It looks like a predominant H1N1 season which tends to peak later. There’s still time to get your flu vaccine. #VaccinesWork https://t.co/tBwUqj0aTr

4/4 We also urge patients to speak with their pharmacists and healthcare providers to confirm that their product is actually affected by the recall. #FDA has resources via @FDA_Drug_Info for consumers and HCPs. Follow us and visit our ARB recall website https://t.co/HZb3YT0060.

RT @pewtrusts: What is @US_FDA doing to get urgently needed treatments to patients with serious and life-threatening infections? Answers and more from @SGottliebFDA: https://t.co/g0qG7FdHkz

#FDA treats products containing cannabis or cannabis-derived compounds as we do any other FDA-regulated products. These products are subject to the same authorities and requirements as FDA-regulated products containing any other substance. https://t.co/LOpLWuqInx

RT @theNCI: The most commonly used types of e-cigarettes among teens may deliver very high levels of nicotine: https://t.co/yWNxWNHML1 #CancerCurrents https://t.co/mjYbyiQ7Df

RT @FDArecalls: Shamrock Farms Issues Voluntary Recall of 2% Reduced Fat Vanilla Half Gallon Milk Due to Undeclared Almonds https://t.co/VEWjTt0rXf

RT @SecAzar: Happy birthday to the US Public Health Service Commissioned Corps. I’m proud of my colleagues who continue the Comm… https://t.co/OCbWOfrBjp

RT @FDArecalls: Olde York Potato Chips Issues Allergy Alert on Undeclared Milk in One Lot of Clancy's Wavy Potato Chips 10 Oz https://t.co/TTSdoe1qEP

@sarahdespres @US_FDA This is critical public health activity, and excepted work, and it will go on. Our very dedicated professionals who will continue this mission will, however, be working subject to other limitations, that affect salary and reimbursement, as a result of the lapse in appropriations.

THREAD: We have received questions about how much user fee funding we have as carryover balances from 2018; to allow us to continue to work on user-fee related applications and medical product development programs. Some facts and details here:

First a few facts: We cannot accept new 2019 user fees which means we cannot accept new medical product applications, unless it is user-fee-program related but doesn’t require the payment of a user fee; which is a very small subset of applications.

#FDA is a critical institution that provides services and protections Americans depend on to sustain, improve their lives. We continue our mission through challenging circumstances. I’m grateful to our professional staff, who are carrying on that mission amidst personal challenge

But we continue work on existing applications where user fees were paid prior to Dec. 22, 2018. Among our medical product user fee programs, the one that will run out of carryover balance first is likely PDUFA which funds new drug review. We have about one month of funding left.